CARR vs QNCX · P/E 43, rev $21.75B vs $79.3M cap
Carrier Global Corp (CARR) versus Quince Therapeutics, Inc. (QNCX) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
QNCX does not have a complete income-statement cache yet.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. QNCX currently screens at market cap $79.3M.
Not investment advice. Open the CARR and QNCX stock pages for the full models.
Not investment advice.